Jonathan Halevy, MD
Cardiovascular Disease · Augusta, MENPI 1649546268
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (56.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 79.3% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2020 at $12,500 and has fallen 54.1% since, to $5,732 in 2022. Among cardiovascular disease clinicians in ME with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 50 payments — averaging $440.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$17K
- Abbott$2K
- Medical Device Business Services, Inc.$1K
- Biotronik Inc.$1K
What the payments were for
- Grants$12,50057%
- Travel & lodging$8,27538%
- Food & beverage$1,0635%
- Education$1951%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 34 | $17,473 |
| Abbott | 3 | $2,089 |
| Medical Device Business Services, Inc. | 11 | $1,266 |
| Biotronik Inc. | 2 | $1,206 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$1,332
- ENSITE$1,251
- Carto 3 System$1,006
- ENSITE PRECISION$828
- CLARIA MRI QUAD CRT-D SURESCAN$358
- CONSULTA CRT-P$225
How this compares
$22,033 in reported general payments places this provider in the 95th percentile of 99 cardiovascular disease providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 94 | $132,880 |
| JardianceEmpagliflozin | 64 | $81,936 |
| XareltoRivaroxaban | 13 | $19,381 |
| OzempicSemaglutide | 12 | $19,221 |
| Repatha SureclickEvolocumab | 11 | $10,434 |
| Praluent PenAlirocumab | 12 | $5,670 |
| Rosuvastatin Calcium | 106 | $1,845 |
| Metoprolol Succinate | 130 | $1,325 |
| Ezetimibe | 46 | $1,291 |
| Atorvastatin Calcium | 140 | $1,281 |
| Torsemide | 52 | $1,055 |
| Spironolactone | 113 | $860 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 36 | $820 |
| Carvedilol | 97 | $664 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 28 | $659 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Augusta
- Kevin WhiteAugusta$194
- Ronald RosenfeldPerry$51K
- Jeffrey ColnesYork$22K
- Howard GlassWestbrook$13K
- Jaidip ChakravarttiScarborough$8K
- Adam KarpmanPortland$7K
- Marco DiazScarborough$6K
- Bram GellerPortland$5K
- Gemini YesodharanLewiston$4K
- Shiva AnnamalaiScarborough$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.